AZD3676 is a drug which acts as a potent and selective antagonist for the 5-HT1A receptor and 5-HT1B receptors, with some selectivity for 5-HT1A. It has been researched for potential applications in the treatment of cognitive impairment in Alzheimer's disease.
See also DU-125530 GSK-588045 SB-272183 WAY-100635
References